EC Number |
Inhibitors |
Structure |
---|
2.3.1.16 | (1R',4S',6R')-(+)-2-[(1-methyl-1H-imidazol-4-yl)sulfonyl]-N-[4-(propan-2-yloxy)phenyl]-2-azabicyclo[2.2.2]octane-6-carboxamide |
selective over other human ELOVL sub-types, good microsomal stability |
|
2.3.1.16 | (1R',4S',6R')-(+/-)-2-(butylsulfonyl)-N-[4-(propan-2-yloxy)phenyl]-2-azabicyclo[2.2.2]octane-6-carboxamide |
racemic mixture of endo-isomers, the exo isomers are inactive |
|
2.3.1.16 | (1R',4S',6R')-(+/-)-2-(phenylsulfonyl)-N-[4-(propan-2-yloxy)phenyl]-2-azabicyclo[2.2.2]octane-6-carboxamide |
racemic mixture of endo-isomers, the exo isomers are inactive |
|
2.3.1.16 | (1R',4S',6R')-(+/-)-N-[4-(propan-2-yloxy)phenyl]-2-(thiophen-3-ylsulfonyl)-2-azabicyclo[2.2.2]octane-6-carboxamide |
racemic mixture of endo-isomers, the exo isomers are inactive |
|
2.3.1.16 | 3-(phenylsulfonyl)-N-[4-(propan-2-yl)phenyl]-8-azabicyclo[3.2.1]octane-8-carboxamide |
- |
|
2.3.1.16 | 3-oxooctanoyl-CoA |
- |
|
2.3.1.16 | 3-[1-(4-chlorophenyl)-5-methyl-3-oxo-2,3-dihydro-1H-pyrazol-4-yl]-6,6-dimethyl-1-phenyl-3-(trifluoromethyl)-3,5,6,7-tetrahydro-1H-indole-2,4-dione |
- |
|
2.3.1.16 | 4-Bromo-2-octenoic acid |
- |
|
2.3.1.16 | 4-fluoro-N-[[2-oxo-6-(1H-pyrazol-1-yl)-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-benzoxazin-4-yl]methyl]benzamide |
- |
|
2.3.1.16 | 4-fluoro-N-[[2-oxo-6-(1H-pyrazol-4-yl)-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-benzoxazin-4-yl]methyl]benzamide |
- |
|